300294 深市 博雅生物

                                  华润博雅生物制药集团股份有限公司

                      2022 年年度非经营性资金占用及其他关联资金往来情况汇总表

                                                                                                                    单位：万元

                    资金占用 占用方与上上市公司 2022 年期初 2022 年年度占用 2022 年年度 2022 年年度2022年年度占用形成

  非经营性资金占用  方名称 市公司的关核算的会占用资金余额 累计发生金额 占用资金的利偿还累计发 期末占用资  原因    占用性质
                              联关系  计科目              （不含利息）  息（如有）  生金额    金余额

控股股东、实际控制人及其                                                                                                                  非经营性占用

附属企业                                                                                                                                  非经营性占用

          小计              -          -        -    0            0                0            0          0          0                -

前控股股东、实际控制人及                                                                                                                  非经营性占用

其附属企业                                                                                                                                非经营性占用

          小计              -          -        -    0            0                0            0          0          0                -

  其他关联方及附属企业                                                                                                                    非经营性占用

          小计                                          0            0                0            0          0          0

        总计            -        -        -  0          0            0          0        0        0            -


其他关联资  资金往来方  往来方与上  上市公司核  2022 年年初往  2022 年度往来  2022 年度往  2022 年度偿还  2022 年年末往  往来形成原

  金往来        名称      市公司的关  算的会计科    来资金余额    累计发生金额  来资金的利  累计发生金额    来资金余额        因        往来性质
                            联关系        目                        (不含利息)    息(如有)

            华润联通（天  受同一母公  应收账款/应

            津）医药有限    司控制    收款项融资      748.44        4,178.82        -        3,372.19      1,555.07      药品销售    经营性往来
                公司

              华润天津医  受同一母公  应收账款/应    118.59        129.63          -          215.91        32.31        药品销售    经营性往来
              药有限公司    司控制    收款项融资

              华润山西医  受同一母公  应收账款/应      30.08        312.57          -          268.54        74.11        药品销售    经营性往来
              药有限公司    司控制    收款项融资

控股股东、实  华润江苏医  受同一母公  应收账款/应    250.03        2,299.99        -        2,319.96        230.06      药品销售    经营性往来
 际控制人及  药有限公司    司控制    收款项融资

 其附属企业                受同一母公  应收账款/应

              华润无锡医                                  8.07          121.73          -          72.63          57.17        药品销售    经营性往来
              药有限公司    司控制    收款项融资

              华润安徽医  受同一母公  应收账款/应      32.47        348.56          -          295.38        85.65        药品销售    经营性往来
              药有限公司    司控制    收款项融资

              华润山东医  受同一母公  应收账款/应      10.92        102.83          -          99.3          14.45        药品销售    经营性往来
              药有限公司    司控制    收款项融资

              华润临沂医  受同一母公  应收账款/应      31.8          323.51          -          276.22        79.09        药品销售    经营性往来
              药有限公司    司控制    收款项融资


其他关联资  资金往来方  往来方与上  上市公司核  2022 年年初往  2022 年度往来  2022 年度往  2022 年度偿还  2022 年年末往  往来形成原

金往来        名称      市公司的关  算的会计科    来资金余额    累计发生金额  来资金的利  累计发生金额    来资金余额        因        往来性质
                            联关系        目                        (不含利息)    息(如有)

            华润济宁医  受同一母公  应收账款/应      9.54          71.55          -          57.24          23.85        药品销售    经营性往来
            药有限公司    司控制    收款项融资

            华润河南医  受同一母公  应收账款/应      59.46          91.17          -          128.6          22.03        药品销售    经营性往来
            药有限公司    司控制    收款项融资

            华润湖北医  受同一母公  应收账款/应    191.05        142.64          -          302.03        31.66        药品销售    经营性往来
            药有限公司    司控制    收款项融资

            华润湖南新  受同一母公  应收账款/应

            特药有限公    司控制    收款项融资      137.12        1,174.78        -        1,131.36        180.54      药品销售    经营性往来
                司

            华润湖南瑞  受同一母公  应收账款/应

            格医药有限    司控制    收款项融资      168.06        341.26          -          501.42          7.9        药品销售    经营性往来
                公司

            华润惠州医  受同一母公  应收账款/应    487.22        5,920.39        -        4,435.18      1,972.43      药品销售    经营性往来
            药有限公司    司控制    收款项融资

            华润海南裕  受同一母公  应收账款/应

            康医药有限    司控制    收款项融资      17.82          519.1          -          442.42          94.5        药品销售    经营性往来
                公司


其他关联资  资金往来方  往来方与上  上市公司核  2022 年年初往  2022 年度往来  2022 年度往  2022 年度偿还  2022 年年末往  往来形成原

金往来        名称      市公司的关  算的会计科    来资金余额    累计发生金额  来资金的利  累计发生金额    来资金余额        因        往来性质
                            联关系        目                        (不含利息)    息(如有)

            华润新疆医  受同一母公  应收账款/应      90.68        172.72          -          263